肺癌晚期患者的临终护理对患者生存质量的影响分析(3)
[5] Philip J， Hudson P， Bostanci A， et al. Metastatic non-small cell lung cancer： a benchmark for quality end-of-life cancer care. Med J Aust. 2015. 202(3)： 139-43.
[6] Lim RB. End-of-life care in patients with advanced lung cancer. Ther Adv Respir Dis. 2016. 10(5)： 455-67.
[7] Horne G， Payne S， Seymour J. Do patients with lung cancer recall physician-initiated discussions about planning for end-of-life care following disclosure of a terminal prognosis. BMJ Support Palliat Care. 2016 .
, 百拇医药
[8] Cherif J. Lung cancer up to date. Tunis Med. 2014. 92(1)： 114.
[9] Crawford EJ， Moudgil H， Srinivasan K， Naicker T， Ahmad N. Coordination of end-of-life care for patients with lung cancer and those with advanced COPD： a letter of response. NPJ Prim Care Respir Med. 2014. 24： 14030.
[10] Wang Z， Li YS， Zhao N， Yang JJ， Tu HY， Wu YL. Do-not-resuscitate orders among advanced-stage Chinese lung cancer patients who died in hospital. Support Care Cancer. 2016. 24(4)： 1763-9.
, 百拇医药
[11] Janssens A， Teugels L， Kohl S， Michielsen T， van Meerbeeck JP. Integrating early palliative care (EPC) in the management of lung cancer： The role of the thoracic oncologist. Lung Cancer. 2015. 90(2)： 135-8.
[12] Round J， Jones L， Morris S. Estimating the cost of caring for people with cancer at the end of life： A modelling study. Palliat Med. 2015. 29(10)： 899-907.
[13] Kim SJ， Han KT， Kim TH， Park EC. Does hospital need more hospice beds？ Hospital charges and length of stays by lung cancer inpatients at their end of life： A retrospective cohort design of 2002-2012. Palliat Med. 2015. 29(9)： 808-16.
, 百拇医药
[14] Bremner KE， Krahn MD， Warren JL， et al. An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data. Palliat Med. 2015. 29(10)： 918-28.
[15] Ford DW， Koch KA， Ray DE， Selecky PA. Palliative and end-of-life care in lung cancer： Diagnosis and management of lung cancer， 3rd ed： American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013. 143(5 Suppl)： e498S-512S.
, 百拇医药
[16] Maynard DW， Cortez D， Campbell TC. 'End of life' conversations， appreciation sequences， and the interaction order in cancer clinics. Patient Educ Couns. 2016. 99(1)： 92-100.
[17] Henson LA， AUID- Oho， Gomes B， et al. Factors associated with aggressive end of life cancer care. Support Care Cancer. 2016. 24(3)： 1079-89.
[18] 周長华， 曲学华， 王凌峰， 徐进志. 肺癌晚期个性化临终护理对濒死状态患者生活质量改善情况及家属满意度分析. 中国临床研究. 2016. 29(7)： 971-973.
[19] 王丽萍， 马莉， 左晓曼. 晚期肺癌患者临终关怀护理体会. 河南职工医学院学报. 2013. 25(5)： 624-625.
[20] Reinke LF， Feemster LC， Backhus LM， Gylys-Colwell I， Au DH. Assessment and Management of Symptoms for Outpatients Newly Diagnosed With Lung Cancer. Am J Hosp Palliat Care. 2016. 33(2)： 178-83., 百拇医药(吴晓 戈蕾 龚蕴珍)
[6] Lim RB. End-of-life care in patients with advanced lung cancer. Ther Adv Respir Dis. 2016. 10(5)： 455-67.
[7] Horne G， Payne S， Seymour J. Do patients with lung cancer recall physician-initiated discussions about planning for end-of-life care following disclosure of a terminal prognosis. BMJ Support Palliat Care. 2016 .
, 百拇医药
[8] Cherif J. Lung cancer up to date. Tunis Med. 2014. 92(1)： 114.
[9] Crawford EJ， Moudgil H， Srinivasan K， Naicker T， Ahmad N. Coordination of end-of-life care for patients with lung cancer and those with advanced COPD： a letter of response. NPJ Prim Care Respir Med. 2014. 24： 14030.
[10] Wang Z， Li YS， Zhao N， Yang JJ， Tu HY， Wu YL. Do-not-resuscitate orders among advanced-stage Chinese lung cancer patients who died in hospital. Support Care Cancer. 2016. 24(4)： 1763-9.
, 百拇医药
[11] Janssens A， Teugels L， Kohl S， Michielsen T， van Meerbeeck JP. Integrating early palliative care (EPC) in the management of lung cancer： The role of the thoracic oncologist. Lung Cancer. 2015. 90(2)： 135-8.
[12] Round J， Jones L， Morris S. Estimating the cost of caring for people with cancer at the end of life： A modelling study. Palliat Med. 2015. 29(10)： 899-907.
[13] Kim SJ， Han KT， Kim TH， Park EC. Does hospital need more hospice beds？ Hospital charges and length of stays by lung cancer inpatients at their end of life： A retrospective cohort design of 2002-2012. Palliat Med. 2015. 29(9)： 808-16.
, 百拇医药
[14] Bremner KE， Krahn MD， Warren JL， et al. An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data. Palliat Med. 2015. 29(10)： 918-28.
[15] Ford DW， Koch KA， Ray DE， Selecky PA. Palliative and end-of-life care in lung cancer： Diagnosis and management of lung cancer， 3rd ed： American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013. 143(5 Suppl)： e498S-512S.
, 百拇医药
[16] Maynard DW， Cortez D， Campbell TC. 'End of life' conversations， appreciation sequences， and the interaction order in cancer clinics. Patient Educ Couns. 2016. 99(1)： 92-100.
[17] Henson LA， AUID- Oho， Gomes B， et al. Factors associated with aggressive end of life cancer care. Support Care Cancer. 2016. 24(3)： 1079-89.
[18] 周長华， 曲学华， 王凌峰， 徐进志. 肺癌晚期个性化临终护理对濒死状态患者生活质量改善情况及家属满意度分析. 中国临床研究. 2016. 29(7)： 971-973.
[19] 王丽萍， 马莉， 左晓曼. 晚期肺癌患者临终关怀护理体会. 河南职工医学院学报. 2013. 25(5)： 624-625.
[20] Reinke LF， Feemster LC， Backhus LM， Gylys-Colwell I， Au DH. Assessment and Management of Symptoms for Outpatients Newly Diagnosed With Lung Cancer. Am J Hosp Palliat Care. 2016. 33(2)： 178-83., 百拇医药(吴晓 戈蕾 龚蕴珍)